Related Experiment Videos
Bimodal distribution of serum trypotphan level.
Acta Psychiatrica Scandinavica
|July 1, 1979
Summary
Treatment for endogenous depression with L-tryptophan (L-TP) and electroconvulsive therapy (ECT) resulted in bimodal L-TP serum levels. This suggests a genetic influence on L-tryptophan levels during depression treatment.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Endogenous depression is a complex mood disorder.
- L-tryptophan (L-TP) is a precursor to serotonin, a key neurotransmitter.
- Electroconvulsive therapy (ECT) is a treatment for severe depression.
Purpose of the Study:
- To investigate the effect of L-tryptophan (L-TP) and electroconvulsive therapy (ECT) on serum L-TP levels in patients with endogenous depression.
- To explore potential correlations between L-TP levels and treatment response or characteristics.
Main Methods:
- Serum total L-tryptophan (L-TP) levels were measured before and during treatment.
- Patients received L-TP (6 g daily) and unilateral ECT.
- Statistical analysis was performed to compare L-TP levels and clinical variables.
Main Results:
- Initial L-TP concentrations shifted from a Gaussian to a bimodal distribution during treatment.
- Two distinct groups emerged: low-concentration and high-concentration L-TP levels.
- Patients in the high-concentration group required more ECT sessions, possibly due to L-TP's effect on seizure duration.
Conclusions:
- The observed bimodality of L-TP levels during depression treatment may be genetically determined.
- L-tryptophan supplementation and ECT can alter L-TP serum concentrations.
- Further research is needed to elucidate the genetic basis and clinical implications of these findings.